Pleasanton, CA, United States of America

Maciej Laskowski

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Roche Molecular Systems, Inc.. Active years: 2021-2022.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Maciej Laskowski

Introduction

Maciej Laskowski is an accomplished inventor based in Pleasanton, CA. He has made significant contributions to the field of cancer treatment planning through his innovative designs and technologies. With a total of 3 patents to his name, Laskowski continues to push the boundaries of medical technology.

Latest Patents

Among his latest patents is a display screen or portion thereof with a graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning. This invention aims to enhance the efficiency and effectiveness of cancer treatment by providing clear and interactive guidelines for healthcare professionals.

Career Highlights

Laskowski is currently employed at Roche Molecular Systems, Inc., where he applies his expertise in developing cutting-edge solutions for cancer treatment. His work at Roche has positioned him as a key player in the advancement of molecular diagnostics and personalized medicine.

Collaborations

Throughout his career, Laskowski has collaborated with talented professionals, including Vishakha Sharma and Maciej Chmielarski. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking technologies.

Conclusion

Maciej Laskowski's contributions to the field of cancer treatment planning exemplify the impact of innovation in healthcare. His patents and work at Roche Molecular Systems, Inc. highlight his commitment to improving patient outcomes through technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…